JP2008516909A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008516909A5 JP2008516909A5 JP2007536082A JP2007536082A JP2008516909A5 JP 2008516909 A5 JP2008516909 A5 JP 2008516909A5 JP 2007536082 A JP2007536082 A JP 2007536082A JP 2007536082 A JP2007536082 A JP 2007536082A JP 2008516909 A5 JP2008516909 A5 JP 2008516909A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- disease
- symptoms
- symptom
- receptor agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC(C(c(cc1)ccc1O)O)NCCc(c(*)c1)cc(*)c1OCC(*)=O Chemical compound CC(C(c(cc1)ccc1O)O)NCCc(c(*)c1)cc(*)c1OCC(*)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004050952A DE102004050952A1 (de) | 2004-10-18 | 2004-10-18 | Pharmazeutische Zusammensetzung zur Behandlung von Beschwerden, die mit krankhaften Veränderungen oder Irritationen der Prostata verbunden sind |
| US62459004P | 2004-11-03 | 2004-11-03 | |
| PCT/EP2005/010975 WO2006042679A1 (de) | 2004-10-18 | 2005-10-12 | Verwendung eines beta-3-agonisten zur behandlung von beschwerden der prostata und des unteren urogenitaltrakts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008516909A JP2008516909A (ja) | 2008-05-22 |
| JP2008516909A5 true JP2008516909A5 (https=) | 2008-11-27 |
Family
ID=36202691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007536082A Pending JP2008516909A (ja) | 2004-10-18 | 2005-10-12 | 前立腺及び下部泌尿生殖路の病気を治療するためのβ−３アゴニストの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060084700A1 (https=) |
| EP (1) | EP1804778A1 (https=) |
| JP (1) | JP2008516909A (https=) |
| CA (1) | CA2580170A1 (https=) |
| TW (1) | TW200630083A (https=) |
| WO (1) | WO2006042679A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
| UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
| JPWO2007061114A1 (ja) * | 2005-11-28 | 2009-05-07 | キッセイ薬品工業株式会社 | 神経因性疼痛の予防又は治療用医薬組成物 |
| JP2009541443A (ja) | 2006-06-30 | 2009-11-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 尿失禁及び関連疾患の治療のためのフリバンセリン |
| WO2008121268A1 (en) * | 2007-03-29 | 2008-10-09 | Merck & Co., Inc. | Combination therapy for the treatment-of lower urinary tract symptoms |
| NZ599233A (en) * | 2009-10-07 | 2013-04-26 | Merck Sharp & Dohme | Combination therapy using a beta 3 adrenergic receptor agonist and an antimuscarinic agent |
| US9522129B2 (en) | 2010-08-03 | 2016-12-20 | Velicept Therapeutics, Inc. | Pharmaceutical Combination |
| BR112013002511A2 (pt) * | 2010-08-03 | 2017-06-27 | Altherx Inc | combinações de agonistas de receptores adrenérgicos beta - 3 e antagonistas receptores muscarínicos para tratamento da bexica hiperativa |
| US9907767B2 (en) | 2010-08-03 | 2018-03-06 | Velicept Therapeutics, Inc. | Pharmaceutical compositions and the treatment of overactive bladder |
| CN107205964A (zh) | 2014-12-03 | 2017-09-26 | 威力塞帕特治疗股份有限公司 | 使用调节释放索拉贝隆用于下尿路症状的组合物和方法 |
| CN108290824B (zh) | 2015-10-23 | 2022-03-11 | B3Ar治疗股份有限公司 | 索拉贝隆两性离子及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5116615A (en) * | 1989-01-27 | 1992-05-26 | Immunolytics, Inc. | Method for treating benign prostatic hypertrophy |
| MY126489A (en) * | 1998-07-08 | 2006-10-31 | Kissei Pharmaceutical | Phenoxyacetic acid derivatives and medicinal compositions containing the same |
| MXPA04002449A (es) * | 2001-09-13 | 2004-07-23 | Kissei Pharmaceutical | Cristales de derivado de hidroxinorefedrina. |
| DE10251170A1 (de) * | 2002-10-31 | 2004-05-13 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
| EP1539181B1 (en) * | 2003-04-04 | 2007-06-27 | Dynogen Pharmaceuticals Inc. | Method of treating lower urinary tract disorders |
| US20050222247A1 (en) * | 2003-12-13 | 2005-10-06 | Bayer Healthcare Ag | Chroman derivatives |
-
2005
- 2005-10-12 WO PCT/EP2005/010975 patent/WO2006042679A1/de not_active Ceased
- 2005-10-12 EP EP05799213A patent/EP1804778A1/de not_active Withdrawn
- 2005-10-12 JP JP2007536082A patent/JP2008516909A/ja active Pending
- 2005-10-12 CA CA002580170A patent/CA2580170A1/en not_active Abandoned
- 2005-10-17 TW TW094136193A patent/TW200630083A/zh unknown
- 2005-10-18 US US11/252,838 patent/US20060084700A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006523216A5 (https=) | ||
| JP2007514005A5 (https=) | ||
| JP2008539268A5 (https=) | ||
| JP2009506117A5 (https=) | ||
| JP2011522816A5 (https=) | ||
| JP2005506370A5 (https=) | ||
| JP2008516909A5 (https=) | ||
| JP2005527599A5 (https=) | ||
| EP2283843A3 (en) | Opioids for the treatment of the chronic obstructive pulmonary disease (COPD) | |
| JP2007504174A5 (https=) | ||
| JP2012512158A5 (https=) | ||
| JP2010518122A5 (https=) | ||
| JP2009535370A5 (https=) | ||
| WO2008058288A3 (en) | Sustained release methotrexate formulations and methods of use thereof | |
| JP2012502037A5 (https=) | ||
| JP2011516417A5 (https=) | ||
| JP2008539267A5 (https=) | ||
| JP2009537554A5 (https=) | ||
| JP2008528761A5 (https=) | ||
| JP2008513510A5 (https=) | ||
| JP2010500284A5 (https=) | ||
| JP2008536853A5 (https=) | ||
| JP2009504774A5 (https=) | ||
| JP2009518415A5 (https=) | ||
| JP2003520208A5 (https=) |